Biotechnology company Islet Sciences has announced the receipt of a Japanese patent for allowed claims covering new medications for diabetes.
The notice of allowed claims for Patent Application No. 2008-529208 includes the use and composition for small molecules in preventing or treating pathological inflammatory or autoimmune condition – in particular, type 1 diabetes, atherosclerosis, type 2 diabetes, disorders related to visceral obesity, multiple sclerosis, inflammatory bowel disease, psoriasis, rheumatoid arthritis, and Alzheimer’s disease.
The patent signifies an additional aspect to the value of Islet Sciences’ therapies, which represent a large market opportunity for the diabetic community and also for the company’s stakeholders. Islet Sciences’ focus is on researching, developing, and commercializing patented technologies for people with diabetes.
“We are pleased to announce this significant milestone, which clearly strengthens our global value proposition,” said Islet Sciences Chairman and CEO John Steel. “This patent provides further evidence for the value and promise of this technology to be developed for treatments for diabetes and related complications.”
A development-stage biotechnology company, Islet Sciences possesses patented technologies that are focused on infusion for individuals with insulin-dependent diabetes. Included in the company’s infusion technology are methods for the culturing, isolation, maturation, and immunoprotection (microencapsulation) of islet cells. Islet Sciences’ mission includes introducing commercial products that are relevant to the insulin-dependent diabetes marketplace, including diagnostics and anti-inflammatory compounds.
For more information, visit www.isletsciences.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment